Literature DB >> 33315518

The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China.

Ying Liu1, Jingjing Ren1, Zikang Wu2, Lingzhi Shen3, Huan Shan4, Xuewei Dai5, Jing Li6, Yan Qiu1, Wen Ren1, Jun Yao3, Lanjuan Li7.   

Abstract

Prevalence of hepatitis B (HB) remains high among adults in insular regions of southeast China. To address this issue, large-scale HB vaccination was implemented in Putuo County of Zhoushan City in 2013. To examine the effects of this large-scale HB vaccination, a cross-sectional serological survey was conducted on two isolated islands, Putuo (intervention group) and Dinghai (control group) Counties of Zhoushan City in southeastern China five years later. The data showed lower prevalence of HBsAg and negative results for all HBV markers in the intervention group compared to the control group (4.2% and 6.0%, 20.8% and 33.0%), while the positive rate for anti-HBs and only anti-HBs were higher (68.4% and 53.4%, 47.9% and 34.3%). Therefore, large-scale adult HB vaccination could lower the HB epidemic level. However, the proportion of susceptible people who were negative for all HBV markers remained high. Hence, several additional measures to limit the spread of HBV should be taken by the government.

Entities:  

Keywords:  Hepatitis B virus; immune effect; immunization; vaccination; vaccine

Mesh:

Substances:

Year:  2020        PMID: 33315518      PMCID: PMC8078683          DOI: 10.1080/21645515.2020.1814096

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  15 in total

Review 1.  Healthy adult vaccination: An urgent need to prevent hepatitis B in China.

Authors:  Yan Qiu; Jingjing Ren; Jun Yao
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

3.  Responses to hepatitis B vaccine in isolated anti-HBc positive adults.

Authors:  Jun Yao; Wen Ren; Yongdi Chen; Zhenggang Jiang; Lingzhi Shen; Huan Shan; Xuewei Dai; Jing Li; Ying Liu; Yan Qiu; Jingjing Ren
Journal:  Hum Vaccin Immunother       Date:  2016-04-11       Impact factor: 3.452

Review 4.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-03-27

5.  Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.

Authors:  Min Hu; Wen Chen
Journal:  Value Health       Date:  2009 Nov-Dec       Impact factor: 5.725

Review 6.  Update on epidemiology of hepatitis B and C in China.

Authors:  Yan Cui; Jidong Jia
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 7.  Vaccination against hepatitis B: the Chinese experience.

Authors:  Yi-hua Zhou; Chao Wu; Hui Zhuang
Journal:  Chin Med J (Engl)       Date:  2009-01-05       Impact factor: 2.628

Review 8.  The global burden of liver disease: the major impact of China.

Authors:  Fu-Sheng Wang; Jian-Gao Fan; Zheng Zhang; Bin Gao; Hong-Yang Wang
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425

9.  Prevalence of hepatitis B in insular regions of southeast China: a community-based study.

Authors:  Ping Chen; Chengbo Yu; Bing Ruan; Shigui Yang; Jingjing Ren; Weijian Xu; Zhuanbo Luo; Lanjuan Li
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China.

Authors:  Fuqiang Cui; Lipin Shen; Li Li; Huaqing Wang; Fuzhen Wang; Shengli Bi; Jianhua Liu; Guomin Zhang; Feng Wang; Hui Zheng; Xiaojin Sun; Ning Miao; Zundong Yin; Zijian Feng; Xiaofeng Liang; Yu Wang
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.